GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 3,379 shares, a growth of 215.8% from the January 15th total of 1,070 shares. Based on an average daily volume of 25,824 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 25,824 shares, the short-interest ratio is currently 0.1 days.
GeneDx Price Performance
Shares of GeneDx stock opened at $0.02 on Friday. GeneDx has a 12 month low of $0.01 and a 12 month high of $0.34. The business has a fifty day simple moving average of $0.04 and a two-hundred day simple moving average of $0.07.
About GeneDx
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Recommended Stories
- Five stocks we like better than GeneDx
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
